US Patent Issued to LEVICEPT on July 14 for "Therapeutic use of P75NTR neurotrophin binding protein" (British Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,880, issued on July 14, was assigned to LEVICEPT Ltd. (Sandwich, Great Britain).

"Therapeutic use of P75NTR neurotrophin binding protein" was invented by Simon Westbrook (Sandwich, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are therapeutic uses of p75NTR neurotrophin binding proteins and related molecules, such as fusion proteins comprising p75NTR neurotrophin binding proteins and immunoglobulin Fc or portions thereof, in the treatment of osteoarthritis."

The patent was filed on April 20, 2022, under Application No. 17/659,991.

*For further information, including images, charts and tables, please visit: http://pa...